Cobrain Armenia is an innovative brand that aims to enhance the research and innovation capacity of the Yerevan State Medical University. As the first-time-ever succeeded Horizon 2020 project in the university, Cobrain focuses on strengthening the field of brain research, with a special emphasis on neuroprotective cell-based and drug therapies for brain disorders. Through collaboration with renowned institutions such as Eberhard Karls University of Tuebingen, Ruhr-University Bochum, and Lund University, Cobrain works towards establishing a robust neuroscience research structure.

The brand also invests in early stage researchers, widening research career opportunities, building innovation capacity, and increasing the university's visibility. Funded by the European Union's Horizon 2020 research and innovation programme under grant agreement No857600, Cobrain demonstrates a commitment to advancing brain research and finding novel solutions for brain disorders. Located at the Yerevan State Medical University in Armenia, Cobrain is dedicated to making significant contributions to the field of neuroscience.

For more information and to stay updated with Cobrain's latest developments, visit their website or reach out to them via email